This inventor holds 1 USPTO granted patent. Top assignee: Neuland Pharma Research Private Limited. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Mahesh Gattikoppula: Innovator in Pharmaceutical Processes
Introduction
Mahesh Gattikoppula is a notable inventor based in Mahabubabad District, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug preparation. His work is characterized by a commitment to improving existing methodologies and enhancing the efficacy of pharmaceutical compounds.
Latest Patents
Mahesh Gattikoppula holds a patent for the "Process for the preparation of aripiprazole lauroxil." This invention relates to an improved process for synthesizing Aripiprazole Lauroxil, a compound used in the treatment of various mental health conditions. The patent highlights his expertise in pharmaceutical chemistry and his ability to innovate within this critical field. He has 1 patent to his name.
Career Highlights
Currently, Mahesh Gattikoppula is associated with Neuland Pharma Research Private Limited, where he continues to work on advancing pharmaceutical research and development. His role at the company allows him to collaborate with other talented professionals in the industry, contributing to the development of new and effective medications.
Collaborations
Throughout his career, Mahesh has worked alongside notable colleagues such as Ponnaiah Ravi and Neela Praveen Kumar. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective projects.
Conclusion
Mahesh Gattikoppula exemplifies the spirit of innovation in the pharmaceutical industry. His contributions, particularly in the preparation of aripiprazole lauroxil, showcase his dedication to improving drug development processes. His work continues to impact the field positively, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile